Medical AMMedical ModelsPersonalized Medicine

Mentice acquires all assets from Biomodex

The once leading provider of 3D printed vessels and flow systems was valued just €200,000

Stay up to date with everything that is happening in the wonderful world of AM via our LinkedIn community.

Mentice AB (STO: MNTC), a world leader in simulation solutions for image-guided interventional therapies, has acquired all substantial assets from Paris-based company Biomodex for a purchase price of €200,000, following a decision by their board to dissolve operations. The global Biomodex business reached a total turnover of €2.2 million in 2022.

Biomodex specializes in biorealistic 3D printing and flow systems for interventional procedures, with a platform geared towards clinical use and patient-specific simulation. As part of the acquisition, Mentice will also retain key employees of Biomodex. The deal shows that the once-thriving market for 3D printed anatomical models – which helped Biomodex raise capital for several million euros –  is now slowing down. However, the use of 3D printing in the medical segment continued to grow and evolve, with more opportunities in the still niche personalized surgery sector. For example, companies like Insight Surgery are thriving by focusing on patient-specific guides and implants (with bioprinting as the next opportunity on the horizon).

“Biomodex is truly a quality product company, with experienced staff and a large and highly engaged customer base which is a testament to the value they bring to the market”, said Edward Fält, Chief Strategy Officer of Mentice. “Since its inception in 2015, Biomodex has invested over 12 million EUR in IP and R&D, leading to the development of several innovative products and technology advances that will be very synergistic to Mentice’s current portfolio. Thanks to a series of circumstances, we were able to acquire these assets under favorable terms and are now looking forward to taking the business to the next level under the umbrella of the global Mentice organization.”

The acquisition will further consolidate Mentice’s position as the leading provider of virtual, physical and decision-support simulation solutions for image-guided interventional therapies. The acquired assets will add new solutions for neurovascular and structural heart simulation as well as a rapid turn-around production process for direct printing of patient-specific anatomies.

Over the course of 2024, Mentice aims to focus on integrating the Biomodex staff, product lines and production into its existing business areas. As an immediate step, Mentice will be reaching out to all Biomodex customers with more information on the combined offering and how to request product and sales support.

Research
Composites AM 2024

746 composites AM companies individually surveyed and studied. Core composites AM market generated over $785 million in 2023. Market expected to grow to $7.8 billion by 2033 at 25.8% CAGR. This new...

Davide Sher

Since 2002, Davide has built up extensive experience as a technology journalist, market analyst and consultant for the additive manufacturing industry. Born in Milan, Italy, he spent 12 years in the United States, where he completed his studies at SUNY USB. As a journalist covering the tech and videogame industry for over 10 years, he began covering the AM industry in 2013, first as an international journalist and subsequently as a market analyst, focusing on the additive manufacturing industry and relative vertical markets. In 2016 he co-founded London-based VoxelMatters. Today the company publishes the leading news and insights websites VoxelMatters.com and Replicatore.it, as well as VoxelMatters Directory, the largest global directory of companies in the additive manufacturing industry.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button
Close Popup
Privacy Settings saved!
Privacy Settings

When you visit any web site, it may store or retrieve information on your browser, mostly in the form of cookies. Control your personal Cookie Services here.

These cookies are necessary for the website to function and cannot be switched off in our systems.

Technical Cookies
In order to use this website we use the following technically required cookies
  • PHPSESSID
  • wordpress_test_cookie
  • wordpress_logged_in_
  • wordpress_sec

Decline all Services
Save
Accept all Services

Newsletter

Join our 12,000+ Professional community and get weekly AM industry insights straight to your inbox. Our editor-curated newsletter equips executives, engineers, and end-users with crucial updates, helping you stay ahead.